ArticleWorld journal of gastroenterology2025
Assessing deep learning models for multi-class upper endoscopic disease segmentation: A comprehensive comparative study.
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review of Gastrointestinal Capsule Robots: Materials, Actuation, Diagnostics, and Therapeutics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Structural determinants of pulmonary diffusing capacity identified by network analysis and machine learning on quantitative CT.Scientific reports · 2026Article
- Bridging innovation and clinical reality: Interpreting the comparative study of deep learning models for multi-class upper gastrointestinal disease segmentation.World journal of gastroenterology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUpper gastrointestinal (UGI) diseases present diagnostic challenges during endoscopy due to visual similarities, indistinct boundaries, and observer variability, which can lead to missed diagnoses and delayed treatment. Automated segmentation using deep learning (DL) models offers the potential to assist endoscopists, improve diagnostic accuracy, and reduce workload. However, multi-class UGI disease segmentation remains underexplored, with limited annotated datasets and insufficient focus on clinical validation. This study hypothesizes that comparative analysis of different DL architectures can identify models suitable for clinical application, providing actionable insights to reduce diagnostic errors and support clinical decision-making in endoscopic practice.
aimTo evaluate 17 state-of-the-art DL models for multi-class UGI disease segmentation, emphasizing clinical translation and real-world applicability.
methodsThis study evaluated 17 DL models spanning convolutional neural network (CNN)-, transformer-, and mamba-based architectures using a self-collected dataset from two hospitals in Macao and Xiangyang (3313 images, 9 classes) and the public EDD2020 dataset (386 images, 5 classes). Models were assessed for segmentation performance and performance-efficiency trade-off. Statistical analyses were conducted to examine performance differences across architectures. Generalization capability was measured through a cross-dataset evaluation (training models on the self-collected dataset and testing on the EDD2020 dataset).
resultsSwin-UMamba achieved the highest segmentation performance across both datasets [intersection over union (IoU): 89.06% ± 0.20% self-collected, 77.53% ± 0.32% EDD2020], followed by SegFormer (IoU: 88.94% ± 0.38% self-collected, 77.20% ± 0.98% EDD2020) and ConvNeXt + UPerNet (IoU: 88.48% ± 0.09% self-collected, 76.90% ± 0.61% EDD2020). Statistical analyses showed no significant differences between paradigms, though hierarchical architectures with pre-trained encoders consistently outperformed simpler designs. SegFormer achieved the best balance of accuracy and computational efficiency with a performance-efficiency trade-off score of 92.02%, making it suitable for real-time clinical use. Cross-dataset evaluation revealed significant performance drops, with generalization retention rates of 64.78% to 71.52%. Transformer-based models, particularly pyramid vision transformer v2 + efficient multi-scale convolutional decoding (IoU: 63.35% ± 1.44%), generalized better than CNN- and mamba-based models.
conclusionHierarchical architectures like Swin-UMamba and SegFormer show promise for UGI disease segmentation, reducing missed diagnoses and improving workflows, but robust clinical validation is crucial for real-world deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.